Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Motohiko S"'
Autor:
Atsunobu Sagara, Akihito Nagahama, Hayato Aki, Hiroki Yoshimura, Makoto Hiraide, Takatsune Shimizu, Motohiko Sano, Tetsuro Yumoto, Tomoo Hosoe, Kenji Tanaka
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract Background Concerns persist regarding the potential reduction in driving performance due to taking second-generation antihistamines or performing hands-free calling. Previous studies have indicated a potential risk to driving performance und
Externí odkaz:
https://doaj.org/article/1a9d4ef7ad6640d9b4ef832d753e10f3
Autor:
Tomoko Tajiri, Motohiko Suzuki, Hirono Nishiyama, Yoshiyuki Ozawa, Ryota Kurokawa, Norihisa Takeda, Keima Ito, Kensuke Fukumitsu, Yoshihiro Kanemitsu, Yuta Mori, Satoshi Fukuda, Takehiro Uemura, Hirotsugu Ohkubo, Masaya Takemura, Ken Maeno, Yutaka Ito, Tetsuya Oguri, Kenji Izuhara, Akio Niimi
Publikováno v:
Allergology International, Vol 73, Iss 3, Pp 406-415 (2024)
Background: Dupilumab has clinical effects in patients with moderate-to-severe asthma. When considering interleukin (IL)-4 and IL-13 signaling, effects of dupilumab on airway mucus hypersecretion and airway remodeling are expected, but they have been
Externí odkaz:
https://doaj.org/article/54aaf13e615b4d6ba77f3fe4a3a4bbae
Autor:
Yasuhiro Tagawa, Tetsuya Saito, Hideyuki Iwai, Motohiko Sato, Seiji Noda, Akio Yamamoto, Mineto Ota, Kentaro Endo, Hideyuki Koga, Yasuhiro Takahara, Kazutaka Sugimoto, Ichiro Sekiya, Keishi Fujio, Eiryo Kawakami, Fumitaka Mizoguchi, Shinsuke Yasuda
Publikováno v:
Immunological Medicine, Vol 47, Iss 3, Pp 176-185 (2024)
Recent single-cell RNA-sequencing analysis of rheumatoid arthritis (RA) synovial tissues revealed the heterogeneity of RA synovial fibroblasts (SFs) with distinct functions such as high IL-6 production. The molecular mechanisms responsible for high I
Externí odkaz:
https://doaj.org/article/1cb40cc9da364f5fb0a8ec5d5e697aed
Autor:
Yosuke Iijima DDS, PhD, Miki Yamada DDS, Mai Amano MS, Saya Watanabe MS, Miki Fujimaru BS, Ayako Uematsu BS, Shunsuke Hino DDS, PhD, Motohiko Sano PhD, Norio Horie DDS, PhD, Hiroshi Sakagami PhD, Takahiro Kaneko DDS, PhD
Publikováno v:
Gerontology and Geriatric Medicine, Vol 10 (2024)
Purpose: Medication-related osteonecrosis of the jaw (MRONJ) caused by bisphosphonates (BPs) and denosumab (Dmab) is still a major oral adverse event caused by cancer treatment and may be under-recognized by private dental services. With the aim of r
Externí odkaz:
https://doaj.org/article/cea197e083464948a9fbe69e5cd66c95
Autor:
Yuma Shibutani, Kazuko Tajiri, Shinya Suzuki, Tomohiro Enokida, Atsunobu Sagara, Susumu Okano, Takao Fujisawa, Fumiaki Sato, Tetsuro Yumoto, Motohiko Sano, Toshikatsu Kawasaki, Makoto Tahara
Publikováno v:
Cancer Medicine, Vol 12, Iss 22, Pp 20773-20782 (2023)
Abstract Background Hypertension is the most frequently occurring adverse event of lenvatinib, recognized relatively early in its course. However, the trend in blood pressure after the initiation of lenvatinib and the outcomes with antihypertensive t
Externí odkaz:
https://doaj.org/article/25332373f7da40b29df12ef342640d17
Autor:
Hikaru Koga, Takashi Yamano, Juan Betancur, Satoko Nagatomo, Yousuke Ikeda, Kazuki Yamaguchi, Yoshiaki Nabuchi, Kazuki Sato, Yuri Teranishi-Ikawa, Motohiko Sato, Hiroyuki Hirayama, Akira Hayasaka, Takuya Torizawa, Kenta Haraya, Zenjiro Sampei, Hirotake Shiraiwa, Takehisa Kitazawa, Tomoyuki Igawa, Taichi Kuramochi
Publikováno v:
mAbs, Vol 15, Iss 1 (2023)
ABSTRACTEfficient production of bispecific antibodies (BsAbs) in single mammalian cells is essential for basic research and industrial manufacturing. However, preventing unwanted pairing of heavy chains (HCs) and light chains (LCs) is a challenging t
Externí odkaz:
https://doaj.org/article/281415e66ed346d99393535f365215ff
Autor:
Takuya Fujihara, Motohiko Sano, Yutaka Negoro, Shinji Yamashita, Hideya Kokubun, Ryoichi Yano
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 9, Iss 1, Pp 1-7 (2023)
Abstract Background Cancer-related fatigue (CRF) is one of the most common symptoms in patients with cancer. However, CRF has not been sufficiently evaluated as it involves various factors. In this study, we evaluated fatigue in patients with cancer
Externí odkaz:
https://doaj.org/article/0d88ea25824f4131867328014daf2795
Autor:
Takuhiro Yamaguchi, Tempei Miyaji, Tomoe Mashiko, Takashi Kawaguchi, Yusuke Inada, Yasuhiro Nakano, Miyuki Kurosaki, Ouki Kuniyoshi, Motohiko Sano, Tomoki Hatakeyama, Yusuke Tsuchiya, Tomohiko Harada
Publikováno v:
BMJ Open, Vol 13, Iss 9 (2023)
Introduction Symptom-related adverse events associated with perioperative chemotherapy in patients with breast cancer include short-term adverse events such as nausea and vomiting. However, changes in the severity and duration of prolonged symptom-re
Externí odkaz:
https://doaj.org/article/b096416facfd48d789c9661a5ef18b18
Autor:
Keiki Shimada, Daisuke Katagiri, Aika Kato, Naoto Nunose, Motohiko Sato, Yuri Katayama, Kanako Terakawa, Takahito Niikura, Emi Sakamoto, Yuki Yoshizaki, Minami Suzuki, Takashi Fukaya, Takeshi Tamaki, Hideki Takano
Publikováno v:
Renal Replacement Therapy, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract Background Generalized pustular psoriasis (GPP) usually presents with fever, generalized flushing, and multiple sterile pustules on the skin, which histopathologically form subcorneal pustules characterized by Kogoj spongiform pustules. Gran
Externí odkaz:
https://doaj.org/article/0c20b0b73ea64cc99591dc0fe01784e8
Autor:
Yuma Shibutani, Shinya Suzuki, Atsunobu Sagara, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Fumiaki Sato, Tetsuro Yumoto, Motohiko Sano, Toshikatsu Kawasaki, Makoto Tahara
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundProteinuria is the most frequent adverse event of lenvatinib use. However, the association between lenvatinib-induced proteinuria and renal dysfunction remains unclear.MethodsWe retrospectively reviewed medical records of patients with thyr
Externí odkaz:
https://doaj.org/article/bf2ddac6f23a4c23873e4afe40272e95